AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 6,970.00
+380.00 (5.77%)
Oct 16, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 195.81 billion as of October 16, 2026. It is the 22,707th most valuable company in the world and the 843rd biggest in South Korea. Its market cap has decreased by 9.17% in one year.
Market Cap
195.81B
Enterprise Value
185.00B
Revenue
4.75B
Global Rank
Country Rank
#843 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 195.81B, a decrease of -53.74%. That is a compound annual growth rate of -9.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 195.81B | -22.09% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Huons | 210.66B |
| Hyundai Pharmaceutical | 209.80B |
| BNC KOREA | 201.08B |
| Whan In Pharm | 191.49B |
| REYON Pharmaceutical | 182.68B |
| Yungjin Pharm. | 182.16B |
| Chong Kun Dang Holdings | 176.85B |
| FutureChem Co.,Ltd | 175.43B |